SORT BY Relevancy
Donald Jones, Chief Digital Officer, Scripps Translational Science Institute talks with host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer on what's happening with digital in drug development. Don discusses his thoughts on the evolution of new products with digital and the “digitazation” of tools for clinical trials. He also shares his thoughts on the biggest disruptors in pharma.
Don and Craig will be featured in an interview as well at DPharm: Disruptive Innovations to Advance Clinical Trials on September 11, 2014 in Boston.
Head of Clinical Innovation, R&D
Chief Digital Officer
Scripps Translational Science Institute
Founder & Chairman, Wireless Life Sciences Alliance
The Conference Forum
Joyce interviews Nick Firestine from Walgreens Pharmacy on how your pharmacist is an important partner in your good health! We'll be talking about the proper way to dispose of old prescriptions and how having a prescription checkup can save your life!
Joyce Joneschiet (Jonah-shite) Principal interior designer of Encore Living Interiors and Publisher of Encore Life Magazine hosts Encore Living Radio with her co-host Aaron D. Murphy, a licensed Architect, President of ADM Architecture and Managing Editor of EmpoweringTheMatureMind.com.
In Touch Interviews 10-11 a.m. The Clinical Hypnosis Institute will be joining us to discuss their upcoming courses, the variety of hypnosis they offer, what is hypnosis, medical to metaphysical hypnosis, how it can help you and more wonderful topics. Call in with questions. 646-378-0378.
Earlier this week actor/comedian Robin Williams was found dead in his home an apparent suicide. What many people did not realize was that Williams suffered from clinical depression for years. Outwardly the man was all laughs and smiles but on the inside he was fighting a battle for his life. Clinical depression is becoming a more common ailment in today's society, and unfortunately the signs of depression are often missed or ignored. Even though there are celebrities out there who are trying to convince the world it is okay to talk about mental illness the subject is still considered taboo by many.
What IS clinical depression?
Who can be affected by it?
What are the most common treatments?
How common are depression related suicides?
Why does society avoid talking about mental illness?
Can raising awareness make a difference?
Join us on today's show as we attempt to answer these questions and get a dialogue going about mental illness. As always if you wish to call in with your questions or comments phone lines will be open for callers. (646)716-6583
If you can't catch the show live all shows are archived for your listening pleasure.
In Clinical Air episode # 8, host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer hosts a show discussing investigators as partners in clinical research. Guests include:
Christine Pierre, President, Society of Clinical Research
Jacalyn Kent, Director, Clinical Development Information & Optimization, Eli Lilly
Key topics include:
Misunderstandings around Remote Based Monitoring
Training and communication challenges for remote site managers
What are the real cost savings around RBM...are we just shifting costs?
Real time data and how this should affect sites and payments
Reducing burdens to the sites
Investigator turn over rate, making sites sustainable
Join host, Craig Lipset, Head of Clinical Innovation, R&D, Pfizer lead a discussion on Investing in the future of clinical research.
Todd Pietri, Co-Founder, Milestone Ventures
Jeremy Sohn, Managing Director, MPM Capital
VC views on:
Disruption in the clinical trial space
Finding opportunities (incubators and accelerators)
Good sources of deal flows
Investing in technology or people?
Beyond the pill
Craig, Todd and Jeremy will also be speaking at Mobile@Dpharm on September 10th at the Farimont Copley Plaza hotel in Boston. This event helps drug developers get their arms around the mobile/digital clinical trial landscape and figure out:
How mobile is innovating clinical trials
What parts of clinical trials mobile/digital technology is currently impacting
How mobile technology is making clinical trials cheaper, easier and more accurate
How mobile/digital is increasing the efficacy of drugs
What the true value is to clinical trials
There is an opportunity to participate in creating a clinical trial app. Mobile@Dpharm will also be of interest to investors and app developers. Following this one day event is DPharm: Disruptive Innovations to Advance Clinical Trials. For more information, visit www.theconferenceforum.org or call 646 350 2580.
Join host, Craig H. Lipset, Head of Clinical Innovation, R&D, Pfizer lead a discussion on what it really means to partner with patients in clinical trials.
Jeri Burtchell, Founder, Partners in Research
Regina Holliday, Artist and Medical Advocate
For more information on Jeri's new launch, visit: Healthivibe.com and for Regina walking gallary, google Regina Holliday, walking gallary.
For more information on the topic of Patients as Partners, visit www.theconferenceforum.org. The Conference Forum presented a program in March 2014 fully dedicated to understanding the journey a patient takes in clinical trials. Also take a look at Disruptive Innovations to Advance Clinical Trials scheduled for September 11-12, 2014 in Boston. This event addresses significant innovation to help improve a patients experience in a clinical trial.
This show is part of the Leukemia & Lymphoma Society Patient Education Series.
Our special guest is Dr. Christopher Yasenchak from Compass Oncology in Portland, Oregon. Dr. Yasenchak received his M.D. from Pennsylvania State University. He continued his training at the Mayo Clinic College of Medicine and is board certified in hematology, medical oncology and internal medicine. His clinical focus is multiple myeloma, lymphoma, stem cell transplantation, gastrointestinal malignancies and clinical trials.
Dr. Ian Thompson is Professor, Glenda and Gary Woods Distinguished Chair in GU Oncology at The University of Texas Health Science Center, San Antonio. Dr. Ian Thompson received his undergraduate degree from West Point and his M.D. degree from Tulane University. After a Residency in Urology in San Antonio, he completed a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center. Dr. Thompson has published over 400 scientific papers, several dozen book chapters, and has edited five textbooks in medicine and surgery. He currently serves as Vice-Chair of the Early Detection Research Network of the National Cancer Institute and is Chair of the Genitourinary Committee of the Southwest Oncology Group, the largest clinical trials organization supported by the National Cancer Institute. Dr. Thompson is the Principal Investigator of the San Antonio Center for Biomarkers Of Risk of Prostate Cancer. This cohort study, with up to 8 years of followup, currently follows over 3,600 men for development of prostate cancer and has been the source of many recent important developments in the early detection of prostate cancer.
Our prostate cancer panels are conducted in association with Prostate Cancer International and Prostate Cancer Foundation.
RSVP here (or) mail email@example.com
An overview of Ambry's revolutionary form of genetic testing which allows scientists to diagnose many different diseases using far less tests than before. Scientists can now diagnose multiple different diseases with far fewer tests, easing the burden on patients and their families both emotionally as well as financially.
Today's #RxChat Pharmacy Podcast is co-hosted by the American Pharmacist Association. We are pleased to have the direction and insight of Stacie Maass, Senior Vice President, Pharmacy Practice and Government Affairs with APhA.
1. Which services best illustrate the value of pharmacists to the health care team?
2. What does the term “provider status” mean to you?
3. Why do you feel provider status is important?
4. How will provider status affect you as a practitioner?
5. How will provider status affect your patients?
6. What is the most significant barrier to achieving provider status for pharmacists?
Today on HELP! Relationships 102, we confront prevailing yet unrealized ways that we give Depression dominion in our lives! You may be surprised to learn that, if allowed —How GOD gives hope to the hopeless, especially in the face of hopelessness!
Join us as we address unaddressed aspects of this all important issue!
Join Host Live Chats
- SchmidtTalker0 (1 chatters)